QCLS
NASDAQQ/C Technologies Inc.
Q/C Technologies Inc. (QCLS) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. There were no new wire items for QCLS in the last 30 days. The most recent was published Oct 2, 2026.
Financial highlights
Full financials- Net income, TTM
- -$16.57M
- Cash
- $307.6K
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks12-100%
2026-05-172026-11-08
Mix890d
- Insider4(50%)
- SEC Filings2(25%)
- Leadership1(13%)
- Other1(13%)
Activity · 52 weeks4428 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERExecutive Chairman Silverman Joshua was granted 94,010 shares, increasing direct ownership by 80% to 210,845 units (SEC Form 4)4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERAmendment: Executive Chairman Silverman Joshua was granted 16,806 shares, increasing direct ownership by 17% to 116,835 units (SEC Form 4)4/A - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- PRQ/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy LabCollaboration advances Q/C Technologies’ optical processing unit initiative for AI inference through nanophotonics research at Sandia’s Center for Integrated Nanotechnologies SAN FRANCISCO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company"), a developer of next-generation optical computing solutions, today announced a collaboration with the Center for Integrated Nanotechnologies (CINT) at Sandia National Laboratories ("Sandia") to advance its proprietary optical processing unit (OPU) initiative for artificial intelligence inference. The Company is pioneering next-generation optical computing solutions designed to harness the prope
- INSIDERSEC Form 3 filed by new insider Ehrlichman Yossef3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- SECQ/C Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- PRQ/C Technologies Names Yossef Ehrlichman Chief Technology Officer to Lead Optical Processor DevelopmentProprietary silicon photonic architecture targets critical bandwidth, energy efficiency and scalability demands of AI inference Optical processors aim to cut the energy and bandwidth cost of moving data in AI systems SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company"), a developer of next-generation optical computing solutions, today announced the appointment of Chief Technology Officer Yossef ("Yossi") Ehrlichman, Ph.D. Dr. Ehrlichman joined the Company earlier this year as founding manager of photonic integrated circuit (PIC) development and will now lead the Company's optical processing unit (OPU) program and ove
- SECQ/C Technologies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- INSIDERSEC Form 3 filed by new insider Fagan Charles Todd3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- SECSEC Form 10-Q filed by Q/C Technologies Inc.10-Q - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- PRQ/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) DevelopmentSan Francisco, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company"), a developer of next-generation optical computing solutions, today announced the appointment of Yossef Ehrlichman, Ph.D. as Founding Manager, Photonic Integrated Circuit (PIC) Development. Dr. Ehrlichman will lead engineering efforts for the Company's optical processing unit (OPU) initiative, overseeing development of Q/C's proprietary silicon photonic architecture designed to address the increasing performance, bandwidth and energy demands of artificial intelligence inference. Dr. Ehrlichman has more than fifteen years of experience in designing, fabricating and co
- SECQ/C Technologies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- PRQ/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference InitiativeBuilds integrated photonics lab to ramp research and development for proprietary optical processing unit San Francisco, June 30, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company") today announced that it has relocated its headquarters to San Francisco, California, as part of its plan to develop a proprietary optical processing unit (OPU) capable of overcoming the heightened performance and energy constraints of today’s artificial intelligence inference infrastructure. The Company has engaged Lumicity, a U.S. staffing agency specialized in innovative and emerging technologies, to recruit world-class optical, semiconductor and systems enginee
- SECSEC Form 10-Q filed by Q/C Technologies Inc.10-Q - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- INSIDERDirector Voss Chelsea Sierra bought $5,522 worth of shares (1,753 units at $3.15) (SEC Form 4)4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- SECAmendment: SEC Form 10-K/A filed by Q/C Technologies Inc.10-K/A - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- INSIDERSEC Form 4 filed by White Billy Joe4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERSEC Form 4 filed by Friscia Stephen4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERSEC Form 4 filed by Voss Chelsea Sierra4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERSEC Form 4 filed by Bernstein Bruce4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERSEC Form 4 filed by Glass Mitchell4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- INSIDERSEC Form 4 filed by Silverman Joshua4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
- SECSEC Form 10-K filed by Q/C Technologies Inc.10-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- SECSEC Form NT 10-K filed by Q/C Technologies Inc.NT 10-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
- PRQ/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI InferenceNew initiative aimed at developing optical computing technologies to overcome the performance and energy limitations of traditional electronic architectures New York, NY, March 18, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C" or "the Company"), today announced the launch of a new initiative to design and prototype a proprietary optical processing unit (OPU) aimed at tackling the growing performance and energy constraints in artificial intelligence inference infrastructure. Optical computing overcomes challenges posed by electronic GPUs. Artificial intelligence is dominated by one operation: the matrix multiplication. Photons can be configured to perform matrix m
- SECQ/C Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
QCLS FAQ
8 questionsWhat is the latest news on QCLS?
Quantisnow has not tracked any new filings, ratings or press releases for QCLS in the last 30 days. The most recent wire item was published on October 2, 2026.Is QCLS profitable?
No. Q/C Technologies Inc. reported a net loss of $16.57M for the twelve months ended Jun 30, 2026.How much cash and debt does QCLS have?
Q/C Technologies Inc. reported $307.6K in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does QCLS stock trade?
Q/C Technologies Inc. (QCLS) is listed on NASDAQ.What sector and industry is QCLS in?
Q/C Technologies Inc. operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.When did Q/C Technologies Inc. go public?
Q/C Technologies Inc. (QCLS) completed its IPO in 2014.What companies are similar to QCLS?
Notable peers in the same industry include ACHV (Achieve Life Sciences Inc.), LNTH (Lantheus Holdings Inc.), ORKA (Oruka Therapeutics Inc.), NTLA (Intellia Therapeutics Inc.), CLDX (Celldex Therapeutics Inc.). Compare QCLS side-by-side with any of them on Quantisnow.How can I track QCLS on Quantisnow?
Quantisnow aggregates Q/C Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow QCLS to receive live email and push alerts on every new disclosure.